Intravenous recombinant interferon-beta versus interferon-alpha-2b and ribavirin in combination for short-term treatment of chronic hepatitis C patients not responding to interferon-alpha

Scandinavian Journal of Gastroenterology

Volumn 34, Issue 9, 1999, Pages 928-933

  Barbaro, G ^a,b   Di Lorenzo, G ^a,b   Soldini, M ^a,b   Gianeaspro, G ^a,b   Pellicelli, A ^a,b   Grisorio, B ^a,b   Barbarini, G ^a,b   De Rosa, F ^a   Cadario, F ^b   Capelli, D ^b   Filice, G ^b   Paiano, A ^g   Belloni, G ^b   Ferrari, L ^b   Gualandi, G ^c   Poltronieri, I ^c   Barelli, A ^g   Rocchetto, P ^g   Del Poggio, P ^g   Bellomo, G ^d   Calleri, G ^e   Cariti, G ^e   Fruttaldo, L ^g   Mongio F ^g   Rizzo, G ^f   Annese, M ^g   Scotto, G ^g   Bacca, D ^g   Francavilla, R ^g   more..

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c S ANNA HOSPITAL   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

^e Division of Infectious Diseases   (Italy)

^f General Hospital   (Italy)

^g General Hospital ^*

Author keywords

Chronic hepatitis C; Interferon alpha; Interferon beta; Ribavirin

Indexed keywords

ANTIVIRUS AGENT; INTERFERON; PARACETAMOL; RECOMBINANT ALPHA2B INTERFERON; RECOMBINANT BETA INTERFERON; RIBAVIRIN; VIRUS RNA;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL TRIAL; DRUG INDUCED DISEASE; FEMALE; FEVER; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALAISE; MALE; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS HEPATITIS;

ADULT; ANTIVIRAL AGENTS; BIOPSY; DRUG THERAPY, COMBINATION; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; INTERFERON-BETA; LIVER FUNCTION TESTS; MALE; POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; RIBAVIRIN;

EID: 0032888775     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655299750025426     Document Type: Article

References (27)

1. Davis GL., Lau JY, Lim HL. Therapy for chronic hepatitis C. Gastroenterol Clin North Am 1994;23:603-13.
2. Reichard O, Andersson J, Schvarez R, Weiland O. Ribavirin treatment for chronic hepatitis C. Lancet 1991;337:1056-61.
3. Di Bisceglic A, Shindo M, Fong, T-L, Fried MW, Swain MG, Bergasa NV, et al. A pilot study of ribavirin therapy for chronic hepatitis C. Hepatology 1992; 16:649-54.
4. Camps J, Garcia N, Riezu-Boj JI, Civeira MP, Prieto J. Ribavirin in the treatment of chronic hepatitis C unresponsive to alfa interferon. J Hepatol 1993; 19:408-12.
5. Reichard O, Yun Z, Sonneborg A, Weiland O. Hepatitis C viral RNA titers in serum prior to, during and after oral treatment with ribavirin for chronic hepatitis C. J Med Virol 1993:41:99-102.
6. Reichard O, Norkrans G, Fryden A, Braconier J-H, Sonneborg A, Weiland O, et al. Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis C. Lancet 1998;351:83-7.
7. McHutchinson JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998;339:1485-92.
8. Davis GL, Esteban-Mur R, Rustgi V. Hoefs J, Gordon SC. Trepo C, et al. Interferon alpha-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. N Engl J Med 1998;339:1493-9.
9. Barbaro G, Di Lorenzo G, Soldini M, Giancaspro G, Bellomo G, Belloni G, et al. Interferon alpha-2b and ribavirin in combination For chronic hepatitis C patients not responding to interferon alpha alone: an italian multicenter, randomized, controlled, clinical study. Am J Gastroenterol 1998;93:2445-51.
10. Nakano Y, Kiyosawa K, Sodeyama T, Tanaka E. Comparative study of clinical, histological and immunological responses to interferon therapy in type non-A, non-B chronic hepatitis. Am J Gastroenterol 1990;85:24-9.
11. Omata M, Yokosuka O, Takano S, Kato N, Hosoda K, Imazeki F, et al. Resolution of acute hepatitis C after therapy with natural beta interferon. Lancet 1991:338:914-5.
12. Kobayashi Y, Watanabe S, Konishi M, Yokoi M, Kakehashi R, Kaito M, et al. Quantilation and typing of serum hepatitis C virus RNA in patients with chronic hepatitis C treated with interferon beta. Hepatology 1993;18:1319-25.
13. Takano S, Satomura Y, Omata M, Japan Acute Hepatitis Cooperative Study Group. Effect of interferon beta on non-A, non-B acute hepatitis: a prospective, randomized, controlled-dose study. Gastroenterology 1994:107:805-11.
14. Chemello L, Silvestri L, Cavalletto L, Bernardinello E, Pontisso P, Belussi F, et al. Pilot study on the efficacy of intravenous natural beta interferon therapy in Italian patients with chronic hepatitis C and relation to HCV genotype. Int Hepatol Commun 1995;3:237-43.
15. Mazzoran L, Grassi G, Giacca M, Gerini U, Baracetti S, Fanni-Canelles M, et al. Pilot study on the safety and efficacy of intravenous natural beta-interferon therapy in patients with chronic hepatitis C unresponsive to alpha-interferon. Ital J Gastroenterol Hepatol 1997;29:338-42.
16. Okamoto H, Okada S, Sugiyama Y, Yutsomoto S, Tanak T, Yoshizawa H, et al. The 5'terminal sequence of the hepatitis C virus genome. Jpn J Exp Med 1990;60:167-77.
17. Shindo M, Di Bisceglie AM, Cheung L, Shih JW, Feinstone SM, Cristiano K, et al. Decrease in hepatitis C virus RNA during alpha-interferon therapy for chronic hepatitis C. Ann Intern Med 1990; 115:700-4
18. Chomezynski P, Sacchi N, Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-9.
19. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992;73:673-9.
20. Okamoto H, Tokita H, Sakamoto M, Horikita M, Iizuka H, Mishiro S. Characterization of the genomic sequence of the type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. J Gen Virol 1994;75:629-35.
21. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;l:431-5.
22. Armitage P, Berry G Statistical methods in medical research. 3rd ed. Oxford: Blackwell Scientific; 1994.
23. Solko W, Schalm JT, Brouwer L, Chemello L, Alberti A, Bellobuono A, et al. Interferon-ribavirin combination therapy for chronic hepatitis C. Dig Dis Sci 1996;41:131S-4S.
24. Maertens G, Stuyver L. Genotypes and genetic variation of hepatitis C virus. In: Harrison TJ, Zuckerman AJ, editors. The molecular medicine of viral hepatitis. New York; John Wiley & Sons Ltd; 1977. p. 226-7.
25. Simmonds P. Clinical relevance of hepatitis C genotypes. Gut 1997;40:291-3.
26. Perez R, Pravia R, Artimez L, Giganto F, Rodriguez M, Lombrana JLS, et al. Clinical efficacy of intramuscular human interferon beta vs interferon alpha-2b for the treatment of chronic hepatitis C. J Viral Hepatitis 1995;2:103-6.
27. Fesce E, Airoldi A, Mondazzi L, Maggi G, Gubertini G, Bernasconi G, et al. Intramuscolar beta interferon for chronic hepatitis C: is it worth trying? Ital J Gastroenterol Hepatol 1998; 30:185-8.